AMEX · ELMD
Healthcare · Medical - Devices
$27.25
Up+$0.60 (+2.25%)
Updated Sep 12, 2026, 8:06 AM
SID Score
3.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
ELMD closed at $27.25 after 20 trading sessions, down 33.89% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $26.98 | $27.4164 | $26.62 | $27.25 | 96.85K |
| Sep 10, 2026 | $27.18 | $27.225 | $26.64 | $26.65 | 104.55K |
| Sep 9, 2026 | $27.41 | $27.9543 | $26.89 | $27.07 | 78.5K |
| Sep 8, 2026 | $28.00 | $28.04 | $26.83 | $27.51 | 83.19K |
| Sep 4, 2026 | $27.43 | $28.14 | $27.07 | $28.00 | 118.11K |
| Sep 3, 2026 | $28.20 | $28.3916 | $27.43 | $27.61 | 102.25K |
| Sep 2, 2026 | $27.01 | $28.35 | $27.01 | $28.24 | 119.13K |
| Sep 1, 2026 | $29.90 | $29.90 | $26.89 | $27.10 | 167.96K |
| Aug 31, 2026 | $29.00 | $29.37 | $27.81 | $27.97 | 181.63K |
| Aug 28, 2026 | $29.90 | $30.66 | $28.93 | $29.60 | 179.74K |
| Aug 27, 2026 | $31.84 | $32.93 | $29.92 | $30.14 | 177.58K |
| Aug 26, 2026 | $37.96 | $38.38 | $31.53 | $31.77 | 341.83K |
| Aug 25, 2026 | $40.13 | $40.51 | $38.35 | $39.34 | 93.26K |
| Aug 24, 2026 | $40.03 | $41.275 | $39.70 | $40.29 | 58.54K |
| Aug 21, 2026 | $40.00 | $40.715 | $39.26 | $39.45 | 157.12K |
| Aug 20, 2026 | $40.47 | $40.47 | $39.67 | $40.00 | 40.03K |
| Aug 19, 2026 | $41.52 | $41.9999 | $40.49 | $40.87 | 37.57K |
| Aug 18, 2026 | $40.20 | $41.715 | $40.20 | $41.42 | 66.19K |
| Aug 17, 2026 | $41.19 | $41.19 | $39.52 | $40.23 | 77.97K |
| Aug 14, 2026 | $42.69 | $43.2199 | $40.915 | $41.22 | 58.68K |
The latest Smart Investors Daily articles mentioning ELMD.
ELMD research
Company profile and research snapshot.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 26, 2026 | Lake Street | Buy | — |
| May 13, 2026 | B. Riley Securities | Buy | — |
| Nov 13, 2025 | Roth Capital | Buy | — |
| Aug 27, 2025 | Roth Capital | Buy | — |
| Jul 22, 2025 | Roth Capital | Buy | — |
Generated Sep 11, 2026, 9:18 PM
Electromed, Inc. (ELMD) is trading up $0.60 or 2.25% today, driven by investor interest following the company's announcement to participate in two prominent investment conferences. While the conference participation itself is routine corporate activity, it signals management's commitment to engaging with institutional investors and potentially showcasing company developments to a broader audience.
Bottom line: ELMD's modest 2.25% gain appears driven by routine conference participation announcements rather than material business developments. While investor relations activity is positive for long-term shareholder engagement, investors should wait for actual substantive announcements from these conferences—such as product news, financial guidance, or strategic partnerships—to justify a stronger conviction. Monitor the conference presentations and any follow-up management commentary for legitimate catalysts.
Yahoo · Sep 9, 2026
NEW PRAGUE, Minn., September 09, 2026--Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
Yahoo · Sep 3, 2026
On August 25, Electromed (NASDAQ:ELMD) reported fiscal fourth-quarter results that extended a streak few small-cap medical device companies can claim: fifteen consecutive quarters of year-over-year revenue and profit growth. Net revenue hit a record $19.4 million, up 11.6% from a year earlier, and diluted earnings per share climbed to $0.39 from $0.25. Those headline numbers […]
Yahoo · Sep 1, 2026
Home care revenue surged 15.2% as sales rep productivity hit record levels.
SeekingAlpha · Aug 28, 2026
After Electromedâs selloff, explore SmartVest growth drivers, underpenetrated bronchiectasis market, reimbursement outlook, and why the stock looks like a...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ELMD.
